These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5271999)

  • 41. Limitations of the clinical activity of cycloserine therapy. Appearance of resistance to cycloserine when used alone and in combination with other drugs.
    Molina C
    Scand J Respir Dis Suppl; 1970; 71():296-305. PubMed ID: 5272000
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparative studies of cycloserine inhibition of mycobacteria.
    Hawkins JE; McClean VR
    Am Rev Respir Dis; 1966 Apr; 93(4):594-602. PubMed ID: 4956240
    [No Abstract]   [Full Text] [Related]  

  • 43. [In vitro susceptibility of atypical mycobacteria to Cephem and other antibiotics].
    Sakurai N
    Kekkaku; 1983 Jun; 58(6):355-62. PubMed ID: 6620790
    [No Abstract]   [Full Text] [Related]  

  • 44. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activity of biocides against mycobacteria.
    Russell AD
    Soc Appl Bacteriol Symp Ser; 1996; 25():87S-101S. PubMed ID: 8972124
    [No Abstract]   [Full Text] [Related]  

  • 46. [In vitro sensitivity and in vivo resistance of some microbial strains in resuscitation].
    Fava E; Ferrotti A; Picciaiuola E
    G Ital Chemioter; 1969; 16(1):38-49. PubMed ID: 5404125
    [No Abstract]   [Full Text] [Related]  

  • 47. Isolation, identification and drug susceptibility of mycobacteria evaluated through radiometric procedures: correlation by conventional methods.
    Vicini P; Montini G; Ramacciotti PG
    Quad Sclavo Diagn; 1984 Jun; 20(2):226-35. PubMed ID: 6441964
    [No Abstract]   [Full Text] [Related]  

  • 48. [Decomposition of cycloserine in the process of chemical treatment of culture fluid].
    Cheslak I; Bushko N; Makarovskaia-Plotsiennik
    Antibiotiki; 1967 May; 12(5):410-4. PubMed ID: 5593966
    [No Abstract]   [Full Text] [Related]  

  • 49. [Blood bacteriostatic activity in patients with respiratory tuberculosis].
    Manicheva OA; Vishnevskiĭ BI; Ivanova LI; Pavlova MV; Archakova LI
    Probl Tuberk; 2001; (8):24-6. PubMed ID: 11767384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [More rapid detection of multidrug resistance of Mycobacterium tuberculosis in the use of a semiliquid culture medium].
    Manicheva OA
    Probl Tuberk Bolezn Legk; 2005; (11):40-3; discussion 43. PubMed ID: 16405093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular genetic methods for diagnosis and antibiotic resistance detection of mycobacteria from clinical specimens.
    Shamputa IC; Rigouts And L; Portaels F
    APMIS; 2004; 112(11-12):728-52. PubMed ID: 15638836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The biochemical mechanisms of resistance by streptococci to the antibiotics D-cycloserine and O-carbamyl-D-serine.
    Reitz RH; Slade HD; Neuhaus FC
    Biochemistry; 1967 Aug; 6(8):2561-70. PubMed ID: 6058124
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical tolerance to cycloserine.
    Schmelev NA
    Scand J Respir Dis Suppl; 1970; 71():226-30. PubMed ID: 5271990
    [No Abstract]   [Full Text] [Related]  

  • 54. ANTAGONISM OF THE D-ALANINE REVERSAL OF D-CYCLOSERINE ACTION BY L-ALANINE IN MYCOBACTERIUM ACAPULCENSIS.
    MORA J; BOJALIL LF
    Proc Soc Exp Biol Med; 1965 May; 119():49-52. PubMed ID: 14297881
    [No Abstract]   [Full Text] [Related]  

  • 55. [The activity of cycloserine on "paratubercular" mycobacteria].
    MORELLINI M; FERRARI S; FANTOLI U
    Ann Ist Carlo Forlanini; 1960; 20():68-85. PubMed ID: 13772514
    [No Abstract]   [Full Text] [Related]  

  • 56. Susceptibility of Chlamydia to antibacterial drugs: test in cell cultures.
    Gordon FB; Quan AL
    Antimicrob Agents Chemother; 1972 Sep; 2(3):242-4. PubMed ID: 4790565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [On the problem of the mechanism of action of cycloserine stereoisomers on the microbial cell].
    VYSHEPAN ED; IVANOVA KI; LEDNEVA RK
    Biull Eksp Biol Med; 1961 Oct; 52():58-60. PubMed ID: 13927004
    [No Abstract]   [Full Text] [Related]  

  • 58. [Antibacterial effects in culture as a basis for therapy. Methods of measurement and interpretation].
    Bovre K
    Tidsskr Nor Laegeforen; 1972 Mar; 92(8):571-4. PubMed ID: 5021897
    [No Abstract]   [Full Text] [Related]  

  • 59. [Differentiation of Micobacterium fortuitum from other mycobacteria by cycloserine susceptibility test].
    Tsukamura S; Tsukamura M; Mizuno S
    Nihon Saikingaku Zasshi; 1967 Jan; 22(1):18-20. PubMed ID: 6070065
    [No Abstract]   [Full Text] [Related]  

  • 60. [Convulsive effect of cycloserine in experimental conditions].
    KIVMAN GIa; SMOL'NIKOVA NM; IVANOVA GA
    Farmakol Toksikol; 1959; 22():447-50. PubMed ID: 14409535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.